Bioventix plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Bruce Hiscock, was filed 22 Nov 2024.
Bioventix plc: what insiders have been doing
Every trade that managers of Bioventix plc disclose to RNS (LSE) is tracked on this page. The company sits in the Health Care sector. Bioventix plc has had no insider filing for more than a year; the last one goes back to 22 November 2024.
The full history, which starts in 2016, counts 5 purchases against 5 sales.
These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Since the insiders bought
- -8.9%Entry £36.50 · Close at T+365 £33.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended June 2025 · cache
- 0London Stock Exchange, AIM Market (XLON)RNS:5441371Canonical exit: 20 Feb 2025 (T+90)
- 0London Stock Exchange, AIM Market (XLON)RNS:5410652Canonical exit: 28 Jan 2025 (T+90)
- 0London Stock Exchange, AIM Market (XLON)RNS:5162581Canonical exit: 28 Jul 2024 (T+90)
- 0London Stock Exchange, AIM Market (XLON)RNS:5048653
- 0London Stock Exchange, AIM Market (XLON)RNS:4984833Canonical exit: 25 Feb 2024 (T+90)
- 416 shares@ £38.61100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00B4QVDF07FCA-NSM:202110180941PR_NEWS_UKDISCLO_0096Canonical exit: 16 Jan 2022 (T+90)
- 30,000 shares@ £36.0081.1% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00B4QVDF07FCA-NSM:PRNRNS_202004020921PR_NEWS_UKDISCLO_0076_20200403213727077-0
- 18,500 shares@ £13.5018.9% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00B4QVDF07FCA-NSM:PRNRNS_202004020921PR_NEWS_UKDISCLO_0076_20200403213727077-1
- 2,500 shares@ £31.5867100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00B4QVDF07FCA-NSM:PRNRNS_201910281100PR_NEWS_UKDISCLO_0087_20200326185153004_5091
- ▼Executives2M GBP13FCA-NSM
- ▼Executives1M GBP11FCA-NSM
11 of 11 declarations
About Bioventix plc
Bioventix plc is a UK-based company focused on the development and commercialization of antibodies for medical diagnostics. It is listed on the London Stock Exchange under the ticker XLON.
